Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




GE Gets Final Approvals for Instrumentarium Acquisition

By HospiMedica staff writers
Posted on 03 Oct 2003
The remaining regulatory approvals required for its acquisition of Instrumentarium Corp. (Helsinki, Finland) have been received by GE Medical Systems (Waukesha, WI, USA), according to a GE announcement.

These approvals include those of the US Department of Justice and the Canadian Competition Bureau. The European Commission had previously announced approval. GE's tender offer for all Instrumentarium shares and options is set to expire on September 30, 2003. In order to address issues raised by regulators, GE has agreed to divest the Ziehm surgical C-arm business of Instrumentarium. The company has also reconfirmed its agreement with the European Commission to divest the Spacelabs patient monitoring business and to maintain on a global basis the current practice of GE and Instrumentarium of open interfaces for the products covered by the commitments.

GE states that it will announce the results of the company's tender offer on or about October 6, 2003. If the minimum acceptance level is met, tendering shareholders and option holders will receive payment of the offer price on or about October 14, 2003.





Related Links:
Instrumentarium
GE Medical Systems
Digital Intelligent Ferromagnetic Detector
Digital Ferromagnetic Detector
Diagnostic Ultrasound System
DC-80A
Ultrasound Table
Women’s Ultrasound EA Table
Portable X-ray Unit
AJEX140H

Channels

Imaging IT

view channel
Image: Researchers develop a vision-language model trained on large-scale data to generate clinically relevant findings from chest computed tomography images through visual question answering (Ms. Maiko Nagao from Meijo University, Japan)

Interactive AI Tool Supports Explainable Lung Nodule Assessment

Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.